Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior

Nature Genetics

Volumn 44, Issue 2, 2012, Pages 174-177

  Saison, Carole ^a   Helias, Virginie ^a   Ballif, Bryan A ^b   Peyrard, Thierry ^a,c   Puy, Hervé ^d   Miyazaki, Toru ^e   Perrot, Sébastien ^f   Vayssier Taussat, Muriel ^g   Waldner, Mauro ^h   Le Pennec, Pierre Yves ^a,c   Cartron, Jean Pierre ^a   Arnaud, Lionel ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b UNIVERSITY OF VERMONT   (United States)

^c National Reference Center for Blood Groups CNRGS   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e Japanese Red Cross Hokkaido Blood Center   (Japan)

^f UNIVERSITÉ PARIS EST   (France)

^g Institut Scientifique de la Recherche Agronomique   (France)

^h SANTA CHIARA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; BLOOD GROUP JUNIOR ANTIGEN; BREAST CANCER RESISTANCE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN MCF 7; FRAMESHIFT MUTATION; GENE EXPRESSION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; IN VITRO STUDY; JAPANESE; NONSENSE MUTATION; NULL ALLELE; PHENOTYPE; PRIORITY JOURNAL;

ASIAN CONTINENTAL ANCESTRY GROUP; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD GROUP ANTIGENS; CODON, NONSENSE; FEMALE; FRAMESHIFT MUTATION; GYPSIES; HUMANS; NEOPLASM PROTEINS; PREGNANCY; PREVALENCE; URIC ACID;

EID: 84856305947     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.1070     Document Type: Article

References (33)

1. Polgar, O., Robey, R.W. & Bates, S.E. ABCG2: structure, function and role in drug response. Expert Opin. Drug Metab. Toxicol. 4, 1-15 (2008).
2. Noguchi, K., Katayama, K., Mitsuhashi, J. & Sugimoto, Y. Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy. Adv. Drug Deliv. Rev. 61, 26-33 (2009).
3. Helias, V. et al. The human porphyrin transporter ABCB6 is dispensable for erythropoiesis but responsible for the new blood group system Langereis. Nat. Genet. published online, doi:10.1038/mg.1069 (15 January 2012).
4. Kwon, M.Y., Su, L., Arndt, P.A., Garratty, G. & Blackall, D.P. Clinical significance of anti-Jra: report of two cases and review of the literature. Transfusion 44, 197-201 (2004). (Pubitemid 38236381)
5. Peyrard, T. et al. Fatal hemolytic disease of the fetus and newborn associated with anti-Jr. Transfusion 48, 1906-1911 (2008).
6. Nakajima, H. & Ito, K. An example of anti-Jra causing hemolytic disease of the newborn and frequency of Jra antigen in the Japanese population. Vox Sang. 35, 265-267 (1978). (Pubitemid 8401816)
7. Miyazaki, T. et al. A human monoclonal antibody to high-frequency red cell antigen Jra. Vox Sang. 66, 51-54 (1994). (Pubitemid 24017158)
8. Pisacka, M. et al. Six cases of anti-Jra antibody detected in one year-a probable relation with Gypsy ethnic minority from central Slovakia. Proceedings of the 26th Congress of the International Society for Blood Transfusion Vol. 78, 146 (Vienna, 2000).
9. Scharenberg, C.W., Harkey, M.A. & Torok-Storb, B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99, 507-512 (2002). (Pubitemid 34533085)
10. Allikmets, R., Schriml, L.M., Hutchinson, A., Romano-Spica, V. & Dean, M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 58, 5337-5339 (1998). (Pubitemid 28551112)
11. Doyle, L.A. et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA 95, 15665-15670 (1998).
12. Miyake, K. et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res. 59, 8-13 (1999). (Pubitemid 29062946)
13. Vlaming, M.L., Lagas, J.S. & Schinkel, A.H. Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. Adv. Drug Deliv. Rev. 61, 14-25 (2009).
14. Maliepaard, M. et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 61, 3458-3464 (2001). (Pubitemid 32695041)
15. Huls, M. et al. The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int. 73, 220-225 (2008).
16. Zhou, S. et al. Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels. Blood 105, 2571-2576 (2005). (Pubitemid 40387061)
17. Cusatis, G. & Sparreboom, A. Pharmacogenomic importance of ABCG2. Pharmacogenomics 9, 1005-1009 (2008).
18. Imai, Y. et al. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol. Cancer Ther. 1, 611-616 (2002).
19. Lee, S.S. et al. Identification and functional assessment of BCRP polymorphisms in a Korean population. Drug Metab. Dispos. 35, 623-632 (2007).
20. Kobayashi, D. et al. Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab. Dispos. 33, 94-101 (2005). (Pubitemid 40023519)
21. Tamura, A. et al. Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2. Cancer Sci. 98, 231-239 (2007). (Pubitemid 44941876)
22. Dehghan, A. et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 372, 1953-1961 (2008).
23. Kolz, M. et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 5, e1000504 (2009).
24. Woodward, O.M. et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc. Natl. Acad. Sci. USA 106, 10338-10342 (2009).
25. Matsuo, H. et al. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci. Transl. Med. 1, 5ra11 (2009).
26. Jonker, J.W. et al. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. USA 99, 15649-15654 (2002). (Pubitemid 35403986)
27. Puy, H., Gouya, L. & Deybach, J.C. Porphyrias. Lancet 375, 924-937 (2010).
28. Itoda, M. et al. Eight novel single nucleotide polymorphisms in ABCG2/BCRP in Japanese cancer patients administered irinotacan. Drug Metab. Pharmacokinet. 18, 212-217 (2003).
29. Bäckstrom, G. et al. Genetic variation in the ATP-binding cassette transporter gene ABCG2 (BCRP) in a Swedish population. Eur. J. Pharm. Sci. 18, 359-364 (2003). (Pubitemid 36407696)
30. Ballif, B.A., Carey, G.R., Sunyaev, S.R. & Gygi, S.P. Large-scale identification and evolution indexing of tyrosine phosphorylation sites from murine brain. J. Proteome Res. 7, 311-318 (2008). (Pubitemid 351171145)
31. Elias, J.E. & Gygi, S.P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207-214 (2007). (Pubitemid 46358868)
32. Arnaud, L. et al. Identification and characterization of a novel XK splice site mutation in a patient with McLeod syndrome. Transfusion 49, 479-484 (2009).
33. Gouya, L. et al. Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria. Am. J. Hum. Genet. 78, 2-14 (2006). (Pubitemid 41833155)